Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biosimilar”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05406401
What this trial is testing

Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)

Who this might be right for
Lymphoma, Large B-Cell, Diffuse (DLBCL)
Merck Sharp & Dohme LLC 60
Post-approval studies (Phase 4)Study completedNCT04045782
What this trial is testing

Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders

Who this might be right for
Inflammatory Bowel Diseases
Pieter Dewint, MD PhD 130
Not applicableUnknownNCT05427942
What this trial is testing

Yuflyma® (Adalimumab), Patient Experience After Switching

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylarthritisAxial Spondyloarthritis Without Radiographic Evidence of Ankylosing Spondylitis+3 more
Celltrion HealthCare France 300
Large-scale testing (Phase 3)Study completedNCT02016105
What this trial is testing

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira

Who this might be right for
Plaque Type Psoriasis
Sandoz 465
Testing effectiveness (Phase 2)Active Not RecruitingNCT06667050
What this trial is testing

CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
West China Hospital 58
Not applicableEnded earlyNCT02454530
What this trial is testing

Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study

Who this might be right for
Chemotherapy-Induced Neutropenia
Pfizer 1,160
Large-scale testing (Phase 3)Study completedNCT04690556
What this trial is testing

Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Lupin Ltd. 600
Not applicableLooking for participantsNCT06764511
What this trial is testing

Evaluation of Response to Biosimilar Erythropoietin Alfa Therapy in Anemic Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes (MDS)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 60
Not applicableStudy completedNCT03884439
What this trial is testing

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Pfizer 428
Post-approval studies (Phase 4)UnknownNCT02503605
What this trial is testing

Biosimilar Versus Urinary Gonadotropins

Who this might be right for
Infertility
IVI Madrid 130
Testing effectiveness (Phase 2)Study completedNCT03755141
What this trial is testing

Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast CancerMetastatic Breast Cancer
National Cancer Center, Korea 109
Early research (Phase 1)Study completedNCT01933516
What this trial is testing

GP2013 in Japanese Patients With CD20 Positive Low Tumor Burden Indolent B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Indolent B-cell Non-Hodgkin's Lymphoma
Sandoz 6
Large-scale testing (Phase 3)Study completedNCT02787239
What this trial is testing

Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 and Rituximab in Combination With CHOP, in Previously Untreated Subjects With CD20+ DLBCL

Who this might be right for
B-cell Non Hodgkin's Lymphoma
Shanghai Henlius Biotech 407
Early research (Phase 1)Not Yet RecruitingNCT07744828
What this trial is testing

Evaluate Pharmacokinetics of DRL_AB in Healthy Male Participants

Who this might be right for
Healthy Volunteers
Dr. Reddy's Laboratories Limited 160
Early research (Phase 1)Not Yet RecruitingNCT07789964
What this trial is testing

Compare the Pharmacokinetics, Safety, Tolerability, and Immunogenicity of SB35 (Proposed Ixekizumab Biosimilar) to Taltz in Healthy Participants

Who this might be right for
Healthy
Samsung Bioepis Co., Ltd. 174
Not applicableActive Not RecruitingNCT03892655
What this trial is testing

Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Libbs Farmacêutica LTDA 170
Large-scale testing (Phase 3)Study completedNCT02611778
What this trial is testing

Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration (AMD)
Bioeq GmbH 712
Large-scale testing (Phase 3)Study completedNCT01735175
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

Who this might be right for
Neutropenic ComplicationsBreast NeoplasmsChemotherapy-induced Neutropenia+1 more
Sandoz 316
Large-scale testing (Phase 3)Study completedNCT02268045
What this trial is testing

Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
mAbxience Research S.L. 272
Testing effectiveness (Phase 2)Looking for participantsNCT06860490
What this trial is testing

HAIC Combined With Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Fudan University 164
Next Page